ReviewActa pharmaceutica Sinica. B2025

Resistance mutations and the blood-brain barrier: Key challenges in targeted treatment of brain metastatic non-small cell lung cancer.

Jamie Rijmers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.